43 unchanged sentences
Exhibits, Financial Statement Schedules.
−Removed: List the following documents filed as a part of the report:
+Added: (a) List the following documents filed as a part of the report:
(1) Financial statements
2 unchanged sentences
All schedules have been omitted because they are not required or because the required information is given in the financial statements or notes thereto set forth under Item 8 above.
+Added: (3) Exhibits.
A list of exhibits filed with this report or incorporated herein by reference can be found in the Exhibit Index of this Report.
Exhibit Index
+Added: Number Description
3.1 Second Amended and Restated Certificate of Incorporation of Krystal Biotech, Inc.
7 unchanged sentences
333-227632), as filed with the SEC on October 1, 2018)
−Removed: Description of Common Stock
+Added: 4.3* Description of Common Stock (incorporated by reference to Exhibit 4.3 to the Company's Annual Report on Form 10-K (File No.
+Added: 001-38210), as filed with the SEC on March 10, 2020)
10.1# Indemnification Agreement by and between Krystal Biotech, Inc.
10 unchanged sentences
333-220085), as filed with the SEC on September 7, 2017)
−Removed: Executive Employment Agreement, effective May 1, 2017, by and between Krystal Biotech, Inc.
−Removed: and Pooja Agarwal (incorporated by reference to Exhibit 10.4 to the Company’s Amendment No.
−Removed: 1 to the Company’s Registration Statement on Form S-1 (Reg.
−Removed: 333-220085), as filed with the SEC on September 7, 2017)
+Added: 10.4# Executive Employment Agreement, effective January 20, 2020, by and between Krystal Biotech, Inc.
+Added: and Kathryn A.
10.5# Krystal Biotech, LLC 2016 Equity Incentive Plan (incorporated by reference to Exhibit 10.5 to the Company’s Amendment No.
5 unchanged sentences
333-220085), as filed with the SEC on September 14, 2017)
+Added: Number Description
10.7# Krystal Biotech, Inc.
28 unchanged sentences
10.16* Lease Agreement, dated as of December 26, 2019, by and between Northfield I, LLC and Krystal Biotech, Inc.
+Added: 10.17* First Amendment to Lease Agreement, dated as of January 17, 2020, between Northfield I, LLC and Krystal Biotech, Inc.
+Added: 10.18* Second Amendment to Lease Agreement, dated as of August 12, 2020, between Northfield I, LLC and Krystal Biotech, Inc.
+Added: 10.19* Third Amendment to Lease Agreement, dated as of December 14, 2020, between Northfield I, LLC and Krystal Biotech, Inc.
21.1* Subsidiaries of Krystal Biotech, Inc.
23.1* Consent of Mayer Hoffman McCann P.C.
−Removed: Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
−Removed: Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
−Removed: Certification of Principal Executive Officer Pursuant to 18 U.S.C.
+Added: 31.1* Certification of Periodic Report by Chief Executive Officer under Section 302 of the Sarbanes-Oxley Act of 2002.
+Added: 31.2* Certification of Periodic Report by Chief Accounting Officer under Section 302 of the Sarbanes-Oxley Act of 2002.
+Added: 32.1* Certification of Chief Executive Officer Pursuant to 18 U.S.C.
Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: Certification of Principal Financial Officer Pursuant to 18 U.S.C.
+Added: 32.2* Certification of Chief Accounting Officer Pursuant to 18 U.S.C.
Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: XBRL Instance Document
−Removed: XBRL Taxonomy Extension Schema Document
−Removed: XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: XBRL Taxonomy Extension Definition Linkbase Document
−Removed: XBRL Taxonomy Extension Label Linkbase Document
−Removed: XBRL Taxonomy Extension Presentation Linkbase Document
+Added: 101.INS XBRL Instance Document
+Added: 101.SCH XBRL Taxonomy Extension Schema Document
+Added: 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
+Added: 101.DEF XBRL Taxonomy Extension Definition Linkbase Document
+Added: 101.LAB XBRL Taxonomy Extension Label Linkbase Document
+Added: 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document
* Filed herewith.
13 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
−Removed: President and Chief Executive Officer and Director (Principal Executive Officer)
−Removed: March 10, 2020
+Added: Signature Title Date
+Added: Krishnan President and Chief Executive Officer and Director (Principal Executive Officer) March 1, 2021
/s/ Kathryn A.
−Removed: Chief Accounting Officer (Principal Financial Officer)
−Removed: March 10, 2020
−Removed: Chief Operating Officer and Director
−Removed: March 10, 2020
+Added: Romano Chief Accounting Officer (Principal Financial Officer) March 1, 2021
+Added: Krishnan Chief Operating Officer and Director March 1, 2021
/s/ Daniel S.
−Removed: March 10, 2020
−Removed: Douglas Norby
−Removed: Douglas Norby
−Removed: March 10, 2020
−Removed: March 10, 2020
−Removed: /s/ Kirti Ganorkar
+Added: Janney Director March 1, 2021
+Added: Rossi Director March 1, 2021
+Added: /s/ Kirti Ganorkar Director March 1, 2021
Kirti Ganorkar
−Removed: March 10, 2020
−Removed: /s/ Julian Gangolli
−Removed: March 10, 2020
+Added: /s/ Julian Gangolli Director March 1, 2021
Julian Gangolli
+Added: /s/ Chris Mason Director March 1, 2021
+Added: /s/ Jing Marantz Director March 1, 2021
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.